feed,title,long_url,short_url
Benzinga,Basilea's partner Asahi Kasei Pharma completes patient enrolment in phase 3 study with antifungal isavuconazole (Cresemba®) in Japan,https://www.benzinga.com/pressreleases/21/01/g19052990/basileas-partner-asahi-kasei-pharma-completes-patient-enrolment-in-phase-3-study-with-antifungal-i,https://j.mp/3pUcnhu
Benzinga,Basilea's partner Asahi Kasei Pharma completes patient enrolment in phase 3 study with antifungal isavuconazole (Cresemba®) in Japan,https://www.benzinga.com/pressreleases/21/01/tr19052989/basileas-partner-asahi-kasei-pharma-completes-patient-enrolment-in-phase-3-study-with-antifungal-,https://j.mp/3pWgc5F
